Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

RNA interference using boranophosphate siRNAs: structure-activity relationships.

Allison H S Hall1, Jing Wan, Erin E Shaughnessy

  • 1Department of Molecular Genetics and Microbiology, Box 3020, Duke University Medical Center, Durham, NC 27710, USA.

Nucleic Acids Research
|November 17, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Disease risk perception, health intervention intention and their influencing factors among prehypertensive and hypertensive populations: a cross-sectional study with 1050 participants.

BMC public health·2026
Same author

β-Hydroxybutyrate Improves Glucose Metabolism in Streptozotocin-Induced Type 1 Diabetes by Inhibiting Gut and Liver Glucose Transporters via GPR109A.

Diabetes·2026
Same author

Food insecurity and hospital resource utilization.

Journal of hospital medicine·2026
Same author

RNF112 mediates immunosuppression to inhibit the proliferation of cervical cancer by Foxm1.

Translational cancer research·2026
Same author

Multi-Omics Mendelian Randomization and Clinical Validation Implicate NLRP6 as a Candidate Autophagy-Related Gene in Systemic Lupus Erythematosus.

Genes·2026
Same author

AI-derived constrained conditional model for screening marker genes through integrated high-throughput transcriptome big data.

BMC medical research methodology·2026
Same journal

Neurochondrin promotes U5 snRNP maturation by regulating AAR2 release from PRPF8.

Nucleic acids research·2026
Same journal

Elongationless start-stop elements are stress-resilient translation gates that are more repressive than uTranslons.

Nucleic acids research·2026
Same journal

Evolution of the ribosomal exit tunnel through the eyes of the nascent chain.

Nucleic acids research·2026
Same journal

Enhancing the performance and interpretability of epigenetic clocks.

Nucleic acids research·2026
Same journal

FABIAN-variant 2026: improved prediction of the effects of DNA variants on transcription factor binding.

Nucleic acids research·2026
Same journal

Structural and biochemical characterization of Grimontia hollisae thermostable direct hemolysin with DNA reveals first Vibrio hemolysin with nuclease activity.

Nucleic acids research·2026
See all related articles

Boranophosphate siRNAs offer enhanced stability and efficacy for RNA interference (RNAi) therapies compared to other modifications. These modified siRNAs show increased potency and nuclease resistance, making them promising for therapeutic applications.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Drug Discovery

Background:

  • RNA interference (RNAi) utilizes small interfering RNA (siRNA) to silence gene expression.
  • siRNAs require stabilizing modifications for therapeutic use due to nuclease degradation.
  • Phosphorothioate is a common, yet potentially suboptimal, siRNA modification.

Purpose of the Study:

  • To develop and evaluate stereoregular boranophosphate siRNAs.
  • To compare the efficacy and stability of boranophosphate siRNAs against other modifications.
  • To assess the therapeutic potential of boranophosphate-modified siRNAs.

Main Methods:

  • Synthesis of stereoregular boranophosphate siRNAs.
  • In vitro assessment of siRNA efficacy and stability.

Related Experiment Videos

  • Comparison with native and phosphorothioate-modified siRNAs.
  • Main Results:

    • Boranophosphate siRNAs demonstrated superior efficacy compared to phosphorothioate-modified siRNAs.
    • Boranophosphate siRNAs showed increased activity, especially when the antisense strand's center was unmodified.
    • Nuclease resistance of boranophosphate siRNAs was at least tenfold higher than unmodified siRNAs.

    Conclusions:

    • Boranophosphate modification enhances siRNA potency and stability.
    • Boranophosphate siRNAs are more effective and nuclease-resistant than current alternatives.
    • These findings highlight boranophosphate siRNAs as strong candidates for RNAi therapeutics.